World
Health Organization declared "W.. HP. Or" that it had completed the
second phase of its study to the Status of system a new treatment for
tuberculosis, which threatens millions of people around the world.The
organization carried out a clinical study applying the regimen includes
the use of an antibiotic known as the "Gatephluxasin," was to use the
property in question along with other drugs are Isoniazid and Rifampicin
and Baizazanamaid, for four months, instead of the treatment regime
currently in place which lasts for six months, and solve a property known as the "ethambutol" in place of the new drug "Gatephluxasin."The
WHO has indicated, it will be the adoption of the new therapeutic, if
the results of the third phase of this study is similar to the results
of phases I and II, and pointed to the effectiveness of the biggest
advantage of the new pilot for the current system, is scheduled to be
officially announced this stage, which is expected research to be completed by 2009 next.If
the Adoption of the rules new therapeutic, it would be a shorter
regimen interview with tuberculosis will be adopted, according to WHO
figures, the third of the world have already infected the germ of
"Maikobaktirim Taobrkloziz" that cause tuberculosis, and that eight
million people develop the disease is active annually.It
is noteworthy that the spread of HIV, "AIDS" has increased the
difficulty of eliminating tuberculosis, because of reduced immunity to
the first patient, Batalli activate the bacterium tuberculosis in his
lungs that he had sustained earlier.Source: roro 44 and e-mail address is http://healths.roro44.com
ليست هناك تعليقات:
إرسال تعليق